Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human CCL18/PARC Protein
Click to view available options
Quantity:
10 μg
50 μg
Formulation:
Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.
Lyophilized from a 0.2μm filtered solution in Acetonitrile with Trehalose.
Description
The Recombinant Human CCL18/PARC Protein is derived from E. coli. The Recombinant Human CCL18/PARC Protein has been validated for the following applications: Bioactivity.
Specifications
Specifications
| Formulation | Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. |
| Gene ID (Entrez) | 6362 |
| Molecular Weight (g/mol) | 7.8 kDa |
| Name | CCL18/PARC |
| Quantity | 10 μg |
| Source | E. coli-derived human CCL18/PARC protein Ala21-Ala89 |
| Storage Requirements | 12 months from date of receipt, ≤ -20° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, ≤ -20° C under sterile conditions after reconstitution. |
| Conjugate | Unconjugated |
| Recombinant | Recombinant |
| Purity or Quality Grade | 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction